Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
Tickers NEWS SNY
Tags Health Care M&A News
From Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Tickers BX GS GSK HLN
Tags BX Biotech Stories That Matter
From Benzinga
Denali Therapeutics Stock Is Sliding After The Bell: Here's Why
Tickers DNLI NEWS SNY
Tags Market News Expert Ideas Biotech
From Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Tickers ABBV CSLLY GILD GSK
Tags Wall Street's Most Accurate Analysts News Trading Ideas
From Benzinga
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
Tickers RHHBY RXRX SNY SOUN
Tags SNY SOUN RXRX
From Motley Fool
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
Tickers CSLLY GSK NEWS SNY
Tags Benzinga General CSLLY
From Benzinga
Sanofi Sells Global Rights To Rare Autoimmume Drug Enjaymo For $825M Upfront To Italian Firm Recordati
Tickers NEWS SNY
Tags Market News Equities Asset Sales
From Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Tickers AZN MRK NEWS NVO
Tags SNY Large Cap News
From Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
Tickers AZN LLY NEWS NVO
Tags Briefs NVS Regulations
From Benzinga
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
Tickers NEWS REGN SNY
Tags Trading Ideas News Large Cap
From Benzinga
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
Tickers AMGN LLY NEWS SNY
Tags Biotech Stories That Matter Expert Ideas
From Benzinga
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Tickers AMGN CGEM NEWS REGN
Tags Health Care Analyst Color REGN
From Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Tickers GS GSK HLN JNJ
Tags JNJ Briefs MS
From Benzinga
Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences
Tickers NEWS SNY VTYX
Tags Parkinson's Benzinga General
From Benzinga
Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval
Tickers NEWS SNY
Tags Briefs Market News Health Care
From Benzinga
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
Tickers CI CVS LLY NEWS
Tags NVO Market News CVS
From Benzinga
Sanofi's Tolebrutinib Delays Disability Progression In Patients With Multiple Sclerosis, Data Shows
Tickers NEWS SNY
Tags Large Cap SNY News
From Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Tickers NEWS NVS SNY
Tags Benzinga General FDA
From Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
Tickers BNTX JNJ MRNA NVAX
Tags BNTX Market News JNJ
From Motley Fool
Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease
Tickers NEWS REGN SNY
Tags Briefs Market News Biotech
From Benzinga
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
Tickers BMRN BMY GSK LLY
Tags News SNY PFE
From Benzinga
Why Sanofi Stock Was Robustly Healthy Today
Tickers SNY
Tags Recent Press Releases Market News SNY
From Motley Fool
Sanofi Still Bets On Multiple Sclerosis Med Tolebrutinib Despite The Investigational Drug Fell Short In 2 Of 3 Phase 3 Trials
Tickers NEWS SNY
Tags Stories That Matter Biotech why it's moving
From Benzinga
European Stocks Little Moved On Labor Day, German DAX Mark Record Close, Natural Gas Futures Rise: What's Driving Markets Monday?
Tickers BBSRF BMWYY BX EADSY
Tags BBSRF $BTC Market News
From Benzinga
Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates
Tickers LLY NEWS NVO SNY
Tags Stories That Matter AI Generated Media
From Benzinga
Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
Tickers NVAX SNY
Tags SNY Market News NVAX
From Motley Fool
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
Tickers NEWS SNY SPRY
Tags Health Care SNY Trading Ideas
From Benzinga
Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk
Tickers GSK NEWS PFE SNY
Tags Stories That Matter GSK Top Stories
From Benzinga
3 Biotech Stocks to Buy on the Dip: August 2024
Tickers LLY SNY VRTX
Tags Market News VRTX SNY
From InvestorPlace
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
Tickers NEWS SNY SPRY
Tags FDA Stories That Matter Biotech
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.